446286-92-6 Usage
Uses
Used in Pharmaceutical Industry:
5-BROMO-2-(METHYLAMINO)PYRAZINE is used as a key intermediate in the synthesis of various pharmaceutical drugs. Its unique chemical properties allow it to be a valuable component in the development of new medications, contributing to the advancement of healthcare solutions.
Used in Agricultural Chemicals:
In the agricultural sector, 5-BROMO-2-(METHYLAMINO)PYRAZINE serves as an intermediate for the production of agrochemicals. Its application aids in the development of effective crop protection agents and other agricultural products, enhancing crop yields and quality.
Used in Fine Chemicals:
5-BROMO-2-(METHYLAMINO)PYRAZINE is utilized as an intermediate in the manufacture of fine chemicals, which are high-purity chemicals used in various specialized applications. Its presence in these products is crucial for achieving the desired chemical reactions and outcomes.
Used in Research and Development:
5-BROMO-2-(METHYLAMINO)PYRAZINE is employed in research and development processes for the synthesis of new compounds and materials. Its unique properties make it an essential tool for scientists and researchers working on innovative projects in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 446286-92-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,6,2,8 and 6 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 446286-92:
(8*4)+(7*4)+(6*6)+(5*2)+(4*8)+(3*6)+(2*9)+(1*2)=176
176 % 10 = 6
So 446286-92-6 is a valid CAS Registry Number.
InChI:InChI=1/C5H6BrN3/c1-7-5-3-8-4(6)2-9-5/h2-3H,1H3,(H,7,9)
446286-92-6Relevant academic research and scientific papers
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
-
Page 118, (2008/06/13)
This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.
